comparemela.com

Latest Breaking News On - Retina subspecialty day - Page 1 : comparemela.com

Low-dose atropine data, secondary dry eye disease pearls top Healio's AAO 2023 coverage

Low-dose atropine data, secondary dry eye disease pearls top Healio's AAO 2023 coverage
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Megan-baldwin
Eamonn-dreisbach
Arshad-khanani
Byanthony-defino
American-academy-of-ophthalmology
American-academy
Cornea-subspecialty-day
Healio-video-perspective
Retina-subspecialty-day

Adverum Biotechnologies Reports Third Quarter 2023 Financial Results and Pipeline Highlights

Adverum Biotechnologies Reports Third Quarter 2023 Financial Results and Pipeline Highlights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
San-francisco
California
United-states
American
Andrew-ramelmeier
C-david-nicholson
Laurent-fischer
Media-inquiriesadverum-biotechnologies-inc
Drug-administration
Adverum-biotechnologies-inc
Allergan

Why Is Eye Disease-Focused Adverum Bio Stock Trading Higher Today? - Adverum Biotechnologies (NASDAQ:ADVM)

Adverum Biotechnologies Inc (NASDAQ: ADVM) revealed updated data from the OPTIC extension study of ixoberogene soroparvovec (Ixo-vec, formerly referred to as ADVM-022) in patients with wet AMD during the Retina Subspecialty Day at the American Academy of Ophthalmology 

United-states
American
American-academy-of-ophthalmology
Regeneron-pharmaceutical-inc
Retina-subspecialty-day
American-academy
Pharmaceutical-inc

Why Is Eye Disease-Focused Adverum Bio Stock Trading Higher Today?

Adverum Biotechnologies Inc ADVM revealed updated data from the OPTIC extension study of ixoberogene soroparvovec (Ixo-vec, formerly referred to as ADVM-022)…

United-states
American
Adverum-biotechnologies-inc
American-academy-of-ophthalmology
Retina-subspecialty-day
American-academy
News
Ggregator
Reaking-news
Uration
Media

Gene therapy improves diabetic retinopathy severity at 1 year in phase 2 trial

Gene therapy improves diabetic retinopathy severity at 1 year in phase 2 trial
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Markr-barakat
Christine-klimanskis
Byalex-young
American-academy-of-ophthalmology
Retina-subspecialty-day
American-academy
Diabetic-retinopathy-severity-scale
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.